A specific graft-versus-host disease prophylaxis regimen may expand allogeneic hematopoietic stem cell transplant access to ...
Odronextamab combined with CHOP showed high efficacy in untreated DLBCL, with a 100% response rate at the 160 mg dose. The safety profile was manageable, with no new safety signals, and most patients ...
Mastercard's Value Added Services segment is outpacing core growth, and data analytics innovation drives future value. Read ...
Don't perch on your camera-equipped throne assuming your "data" is end-to-end encrypted. It's not quite that simple.
The Aura Plus system delivers fast, decisive, low volume particle characterization to support critical decision making in ...
The launch of a new accessible membership tier and a 47-state clinical expansion strengthen Geviti’s infrastructure for ...
Learn 30 Gemini 3.0 Pro lesser-known features, split across free and pro tiers, helping you speed up reports, writing, and ...
Introduction The COVID-19 pandemic is expected to have impacted many drivers of antimicrobial resistance (AMR) and compounded ...
Decision-making for the optimal management of traumatic knee injuries can be challenging. Clinical trials reveal only small ...
Today’s entertainment market is no longer limited to movie theaters, television networks, and streaming; content creation, ...
Millions of maps are made each day, specifically data-rich maps that guide predictions and decisions for the world’s largest ...
Selinexor-based regimens enhance T-cell activation in RRMM patients, without increasing inhibitory checkpoint molecules, indicating resistance is not due to T-cell exhaustion. Baseline protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback